Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 5 February 2024 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').
The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||
a) |
Name |
Kenny Wilson |
||||||||||
2 |
Reason for the notification |
|||||||||||
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||
a) |
Name |
Dr. Martens plc |
||||||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
|
||||||||||
b) |
Nature of the transaction |
Acquisition of dividend shares under the SIP. |
||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||
d) |
Aggregated information
|
|
||||||||||
e) |
Date of the transaction |
2 February 2024 |
||||||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||
a) |
Name |
Jon Mortimore |
||||||||||
2 |
Reason for the notification |
|||||||||||
a) |
Position/status |
PDMR (Chief Financial Officer) |
||||||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||
a) |
Name |
Dr. Martens plc |
||||||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||||||||
b) |
Nature of the transaction |
Acquisition of dividend shares under the SIP. |
||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||
d) |
Aggregated information
|
|
||||||||||
e) |
Date of the transaction |
2 February 2024 |
||||||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
For further information please contact:
Rebecca Flaherty
Company Secretarial Assistant
+44(0)7570 309775